Literature DB >> 8786971

Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds.

S Fukuyama1, Y Hirasawa, D Cox, S Koda, Y Kita.   

Abstract

PURPOSE: Recently, we have reported that FK409 spontaneously releases nitric oxide (NO) in solution. In the present study, the influence of L-cysteine (Cys) and glutathione (GSH), which are typical sulfhydryl group-bearing compounds, on NO release from FK409 and biological action of FK409 was examined.
METHODS: We evaluated the effects of Cys and GSH on NO release from FK409 by nitrite analysis or detection with a chemiiluminesence analyzer. In a biological study, the influence of Cys on inhibition of rat platelet aggregation of FK409 was investigated. In addition, the above mentioned characteristics of FK409 were compared with those of isosorbide dinitrate (ISDN).
RESULTS: FK409 decomposed spontaneously with generation of nitrite in solution. Both Cys and GSH accelerated decomposition of FK409 and nitrite generation from FK409 in a concentration-dependent manner. When the NO levels in the headspace of FK409 solutions (0.5 mM) reached equilibrium with and without 25 mM Cys, the constant rate for NO release from FK409 in the presence of Cys was 13 times larger than that in the absence of Cys. In biological study, FK409 (100 microM) showed 56 and 90% inhibition of rat platelet aggregation in the absence and presence of 10 mM Cys, respectively, whereas ISDN (100 microM) showed 10 and 23% inhibition, respectively.
CONCLUSIONS: Decomposition of FK409 with generation of NO is spontaneous, and is accelerated in the presence of sulfhydryl group-bearing compounds, thereby potentiating the biological action of FK409.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786971     DOI: 10.1023/a:1016248124104

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Cardiohemodynamic effect of FK409, a novel highly potent nitrovasodilator, in anesthetized dogs.

Authors:  H Yamada; F Yoneyama; K Satoh; N Taira
Journal:  Eur J Pharmacol       Date:  1991-11-19       Impact factor: 4.432

3.  FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  M Hino; M Iwami; M Okamoto; K Yoshida; H Haruta; M Okuhara; J Hosoda; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1989-11       Impact factor: 2.649

4.  Antagonism of glycerol trinitrate activity by an inhibitor of glutathione S-transferase.

Authors:  R A Yeates; M Schmid; M Leitold
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

5.  Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin.

Authors:  R Zelis; D T Mason
Journal:  JAMA       Date:  1975-10-13       Impact factor: 56.272

6.  Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.

Authors:  Y Kita; Y Hirasawa; K Maeda; M Nishio; K Yoshida
Journal:  Eur J Pharmacol       Date:  1994-05-12       Impact factor: 4.432

7.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

8.  Reduction of biological effluents in purge and trap micro reaction vessels and detection of endothelium-derived nitric oxide (edno) by chemiluminescence.

Authors:  N K Menon; J Patricza; T Binder; R J Bing
Journal:  J Mol Cell Cardiol       Date:  1991-04       Impact factor: 5.000

9.  Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.

Authors:  S J Chung; S Chong; P Seth; C Y Jung; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

10.  A new nitric oxide (NO) releaser: spontaneous NO release from FK409.

Authors:  S Fukuyama; Y Kita; Y Hirasawa; T Azuma; A Sato; N Morokoshi; S Koda; T Yasuda; S Oka; H Sakurai
Journal:  Free Radic Res       Date:  1995-11
View more
  1 in total

1.  Nitric oxide (NO)-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds.

Authors:  S Fukuyama; T Azuma; Y Hirasawa; N Morokoshi; T Akama; S Koda; Y Kita
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.